NAV NAVCO Pharmaceuticals Inc

Core Canadian Dividend Trust (the "Fund") (TSX:CDD.UN) announces results of
operations for the year ended December 31, 2013. Net increase in net assets from
operations amounted to $1.3 million or $0.96 per unit. Net assets were $7.6
million or $7.30 per unit, net of distributions to unitholders in the amount of
$0.6 million or $0.45 per unit. 


The Fund's investment objectives are (i) to provide unitholders of the Fund with
monthly distributions targeted to be 6.5% per annum of the net asset value
("NAV") of the Fund; and (ii) to preserve and grow the NAV. The Fund invests in
a blue-chip portfolio consisting of 15 high quality, large capitalization and
dividend paying Canadian companies across multiple industry sectors that have an
excellent long-term track record of dividend growth and share price
appreciation.


The Fund employs a proprietary investment strategy, Strathbridge Selective
Overwriting ("SSO"), to enhance the income generated by the Portfolio and to
reduce volatility. In addition, the Fund may write cash covered put options in
respect of securities in which it is permitted to invest.


The Fund's investment portfolio is managed by its investment manager,
Strathbridge Asset Management Inc. The Fund's units are listed on Toronto Stock
Exchange under the symbol CDD.UN.




--------------------------------------------------------
Selected Financial Information: ($ Millions)            
--------------------------------------------------------
                                                        
Statement of Net Assets                            2013 
                                               -------- 
Assets                                        $     9.6 
Liabilities                                        (2.0)
                                             ---------- 
Net Assets (Unitholders' Equity)              $     7.6 
                                                        
Statement of Financial Operations                       
Revenue                                       $     0.4 
Expenses                                           (0.3)
                                             ---------- 
Net Investment Income                         $     0.1 
Net Gain on Investments                             1.2 
                                             ---------- 
Net Increase in Net Assets from Operations    $     1.3 
--------------------------------------------------------



Aaron Ho, Vice-President, Finance

Commissions, trailing commissions, management fees and expenses all may be
associated with investment funds. Please read the prospectus before investing.
Investment funds are not guaranteed, their values change frequently and past
performance may not be repeated.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Strathbridge Asset Management Inc.
Investor Relations
416.681.3966; 1.800.725.7172
info@strathbridge.com
www.strathbridge.com

Grafico Azioni NAVCO Pharmaceuticals (TSXV:NAV)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni NAVCO Pharmaceuticals (TSXV:NAV)
Storico
Da Giu 2023 a Giu 2024